IgE cancer antibody specialist Epsilogen Ltd has closed a £30.75m round led by Novartis Venture Fund to...
Up To Date
Latest News
AbbVie has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's...
ADC manufacturer Heidelberg Pharma AG has negotiated a US$931m licensing and investment deal with China's...
Paris-based Meletios Therapeutics SA has licenced know-how from the Institut Pasteur for the development of a...
The European Circular Bioeconomy Fund has announced its final closing at €300m, €50m above its target.
TargED Biopharmaceuticals will use €39m from a Series A financing to bring its thrombolytic treatment to...